Development of Diphenyl carbonate-Crosslinked Cyclodextrin Based Nanosponges for Oral Delivery of Baricitinib: Formulation, Characterization and Pharmacokinetic Studies
International Journal of Nanomedicine · 2023
DOI: 10.2147/ijn.s405534 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2023. Verfasst von Mohammed F Aldawsari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj, 11942, Saudi Arabia. Hauptthemen laut MEDLINE: Cyclodextrins, COVID-19. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj, 11942, Saudi Arabia.
- Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University, Buraydah, Al-Qassim, 51452, Saudi Arabia.
ORCID-Profile: Ahmad H Alhowail
Zitieren
APA
Aldawsari, M. F., Alhowail, A. H., Anwer, M. K., & Ahmed, M. M. (2023). Development of Diphenyl carbonate-Crosslinked Cyclodextrin Based Nanosponges for Oral Delivery of Baricitinib: Formulation, Characterization and Pharmacokinetic Studies. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s405534
Vancouver
Aldawsari MF, Alhowail AH, Anwer MK, Ahmed MM. Development of Diphenyl carbonate-Crosslinked Cyclodextrin Based Nanosponges for Oral Delivery of Baricitinib: Formulation, Characterization and Pharmacokinetic Studies. International Journal of Nanomedicine. 2023. doi:10.2147/ijn.s405534
BibTeX
@article{Aldawsari2023,
author = {Aldawsari, Mohammed F and Alhowail, Ahmad H and Anwer, Md Khalid and Ahmed, Mohammed Muqtader},
title = {Development of Diphenyl carbonate-Crosslinked Cyclodextrin Based Nanosponges for Oral Delivery of Baricitinib: Formulation, Characterization and Pharmacokinetic Studies},
journal = {International Journal of Nanomedicine},
year = {2023},
doi = {10.2147/ijn.s405534}
}
EUVIMED